Maximus, Inc. is projected to rise to $65.53 by 2027, a +16% move from its current price of $56.63. MMS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $55.73 | $56.64 | $57.56 | +0.01% |
| Jul 14 | $55.37 | $56.64 | $57.95 | +0.03% |
| Jul 15 | $55.09 | $56.65 | $58.25 | +0.04% |
| Jul 16 | $54.86 | $56.66 | $58.51 | +0.05% |
| Jul 17 | $54.66 | $56.67 | $58.74 | +0.06% |
| Jul 18 | $54.48 | $56.67 | $58.95 | +0.08% |
| Jul 19 | $54.32 | $56.68 | $59.15 | +0.09% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $54.32 | $56.68 | $59.15 | +0.09% |
| Week 2 | $53.41 | $56.73 | $60.26 | +0.18% |
| Week 3 | $52.74 | $56.78 | $61.13 | +0.27% |
| Week 4 | $52.19 | $56.83 | $61.89 | +0.36% |
| Week 5 | $51.71 | $56.89 | $62.57 | +0.45% |
| Week 6 | $51.29 | $56.94 | $63.20 | +0.54% |
| Week 7 | $50.91 | $56.99 | $63.79 | +0.63% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Maximus, Inc. operates as a provider of government services worldwide. The company operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S.
Federal Services segment offers business process services, eligibility and enrollment, outreach, and other services for federal health and human services programs; clinical services; and technology solutions, such as application development and modernization services, enterprise business solutions, advanced analytics and emerging technologies, cybersecurity services, data management, and infrastructure and engineering solutions. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; subsidized telephone services; and person-centered independent assessment services.
This segment also provides employment services, such as eligibility support, case management, job-readiness preparation, job search and employer outreach, job retention and career advancement, and educational and training services; technology solutions; and system implementation project management services. The Outside the U.S. segment offers BPS and technology solutions for international governments, including health and disability assessments, program administration for employment services, wellbeing solutions and other job seeker-related services, digitally-enabled customer services, and technologies for modernization.
Maximus, Inc. was founded in 1975 and is headquartered in McLean, Virginia.
Maximus, Inc. (MMS) is categorized in Industrials. The stock trades at $55.74 per share and has a market cap of $2.93B, with a market ranking of 1772. The current price sits within a broader forecast that envisions growth over the coming years, culminating in substantial upside by 2050.
The forecast highlights bullish momentum in later years, with the average price rising to $87.46 by 2030, $148.70 by 2040, and $303.22 by 2050, accompanied by increasing ROI percentages.
A major floor 14.1% below — a decisive break under it would weaken the trend.
The nearest floor, 5.1% below — buyers have tended to step in here.
The nearest ceiling, 11.0% above — a clean break opens room to run.
A major ceiling 39.1% above — clearing it would confirm fresh momentum.
Key MMS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MMS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $56.68 | Sell | $56.48 | Buy |
| MA 10 | $55.57 | Buy | $56.32 | Buy |
| MA 20 | $56.96 | Sell | $57.04 | Sell |
| MA 50 | $59.97 | Sell | $60.10 | Sell |
| MA 100 | $64.93 | Sell | $65.14 | Sell |
| MA 200 | $76.06 | Sell | $70.81 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 44.88 | Neutral |
| Stoch RSI (14) | 89.67 | Sell |
| CCI (20) | -10.41 | Neutral |
| Williams %R (14) | -17.05 | Info |
| MACD (12,26,9) | 0.36 | Buy |
| ROC (12) | 1.27 | Buy |
| Bollinger %B (20,2) | 0.47 | Neutral |
| Stochastic %K (14) | 82.95 | Sell |
| TRIX (15) | -0.39 | Sell |
| Awesome (5,34) | -2.04 | Sell |
| Ultimate (7,14,28) | 69.82 | Neutral |
| Momentum (10) | 1.56 | Buy |
| Aroon Osc (25) | -44.00 | Sell |
| Hull MA (9) | 57.47 | Sell |
| ADX (14) | 20.50 | Sell |
| ATR (14) | 0.81 | Info |
The near-term technical picture is Neutral. The RSI14 is 30, indicating a neutral reading. The 30-day range spans $49.57 to $62.68, with the current price near the lower end of that range.
The SMA50 sits at $63.22, while the SMA200 sits at $78.37, providing nearby resistance and longer-term trend context. Immediate support is at $55.74 and resistance at $66.66, framing a cautious setup over the coming weeks.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $53.76 | $56.63 | $72.67 | 0% | Neutral | |
| $53.67 | $65.53 | $83.65 | +16% | Neutral | |
| $59.83 | $74.42 | $97.57 | +31% | Bullish | |
| $66.00 | $83.36 | $111.62 | +47% | Bullish | |
| $71.27 | $91.24 | $124.37 | +61% | Bullish | |
| $69.92 | $90.61 | $125.46 | +60% | Bullish | |
| $71.56 | $93.78 | $131.70 | +66% | Bullish | |
| $75.76 | $100.33 | $142.72 | +77% | Bullish | |
| $81.49 | $108.98 | $156.88 | +92% | Bullish | |
| $96.83 | $130.73 | $190.28 | +131% | Bullish | |
| $108.75 | $153.13 | $233.58 | +170% | Bullish | |
| $211.57 | $319.51 | $522.43 | +464% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $53.76 | $56.63 | $65.98 | +0.00% |
| August 2026 | $48.33 | $56.57 | $67.64 | -0.11% |
| September 2026 | $48.72 | $57.30 | $69.05 | +1.29% |
| October 2026 | $47.88 | $56.54 | $68.59 | -1.32% |
| November 2026 | $48.19 | $57.11 | $69.67 | +1.02% |
| December 2026 | $49.85 | $59.27 | $72.67 | +3.77% |
Click any year to see its month-by-month MMS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect MMS to range from $53.76 to $72.67 through 2026. The $56.63 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The MMS price prediction for 2027 points to an average of $65.53 (low $53.67, high $83.65) — a potential gain of +16% on today's $56.63. A consolidation phase looks the most probable path here.
In 2028, MMS is projected to trade between $59.83 and $97.57, averaging $74.42 — a potential gain of +31% from today's $56.63. That is up +14% on the projected 2027 average. Momentum favours further upside here.
Maximus, Inc.'s 2029 outlook centres on $83.36, within a $66.00 to $111.62 range. That is up +12% on the projected 2028 average. That marks a +47% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, MMS could reach as high as $124.37, with a base case around $91.24 and support toward $71.27 — roughly +61% from $56.63. Momentum favours further upside here.
Expect MMS to range from $69.92 to $125.46 through 2031. The $90.61 average target implies a +60% move from current prices. That is -1% versus the projected 2030 average. Buyers look set to stay in control over this stretch.
The MMS price prediction for 2032 points to an average of $93.78 (low $71.56, high $131.70) — a potential gain of +66% on today's $56.63. Momentum favours further upside here.
In 2033, MMS is projected to trade between $75.76 and $142.72, averaging $100.33 — a potential gain of +77% from today's $56.63. That is up +7% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Maximus, Inc.'s 2034 outlook centres on $108.98, within a $81.49 to $156.88 range. That is up +9% on the projected 2033 average. That marks a +92% change versus current levels. Momentum favours further upside here.
By 2035, MMS could reach as high as $190.28, with a base case around $130.73 and support toward $96.83 — roughly +131% from $56.63. Buyers look set to stay in control over this stretch.
Expect MMS to range from $108.75 to $233.58 through 2040. The $153.13 average target implies a +170% move from current prices. That is up +17% on the projected 2035 average. Momentum favours further upside here.
The MMS price prediction for 2050 points to an average of $319.51 (low $211.57, high $522.43) — a potential gain of +464% on today's $56.63. Buyers look set to stay in control over this stretch.
Investing $1,000 in MMS today (≈ 17.658485 MMS) could be worth
$5,642.14
+$4,642.14 (+464%) by 2050 · US Dollar
Based on the average projected MMS price of $319.51 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MMSwould be worth at today's price.
$1,000 invested in MMS on Jul 10, 2025 (≈ 13.743815 MMS) would be worth
$778.31
-$221.69 (-22.2%) today · 0.78× · US Dollar
Based on a MMS entry price of $72.76 vs. today's $56.63.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $55.75 | $1,015.78 | +1.6% |
| 1 month ago | $61.34 | $923.21 | -7.7% |
| 3 months ago | $65.88 | $859.59 | -14.0% |
| 6 months ago | $96.59 | $586.29 | -41.4% |
| 1 year ago | $72.76 | $778.31 | -22.2% |
| All time (5.0y) ago | $88.29 | $641.41 | -35.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MMS forecast.
Our base-case forecast reaches $110.00 around 2035.
Implied market cap at $110.00: $5.78B
The multi-year forecast shows a bullish trajectory after a base period. In 2026 the min and price baseline is $55.74 with an avg of $55.74 and a max of $72.15. The 2027 forecast moves to an avg of $62.82 with a max of $80.34 and a 12.7% ROI.
In 2028 the avg climbs to $74.33 (max $97.59) with a 33.4% ROI, and in 2029 the avg is $81.61 (max $109.41) with a 46.4% ROI. The 2030 forecast shows an avg of $87.46 and a max of $119.34 with a 56.9% ROI, continuing the bullish trend. In 2031 the avg is $89.10 (max $123.49) with a 59.9% ROI, and 2032’s avg is $89.94 (max $126.41) for a 61.4% ROI.
The 2033 forecast yields an avg of $96.33 (max $137.13) with a 72.8% ROI, 2034 an avg of $107.69 (max $155.13) and a 93.2% ROI, and 2035 an avg of $124.55 (max $181.42) with a 123.5% ROI. The outlook for 2040 shows an avg of $148.70 (max $226.93) for a 166.8% ROI, and 2050 the avg climbs to $303.22 (max $495.97) with a 444% ROI. Across these years, the sentiment is generally bullish.
These figures are estimates and are not guaranteed.
Tap a question to reveal the answer.
Avg price is $87.46, with a min of $68.26 and a max of $119.34; ROI is 56.9% and sentiment is bullish.
The forecast shows bullish sentiment from 2028 onward, with the avg price rising to $87.46 by 2030 and to $303.22 by 2050, and ROI reaching up to 444% by 2050. These are estimates, not guarantees.
2030 max is $119.34, which is below $120. By 2031 the max forecast is $123.49, indicating potential to surpass $120 in later years.
Current price is $55.74 and the market cap is $2.93B.
RSI14 is 30 and the 30-day range is $49.57 to $62.68. The SMA50 is $63.22 and the SMA200 is $78.37. Support is at $55.74 and resistance at $66.66.
Maximus, Inc. Community Discussion
0Share your Maximus, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.